MLI's TikTokTivityTM CE like you've never seen before
One educational initiative. Two learning paths. Earn up to 1.25 CME, AAPA, ABIM, MOC Credit
Activity Overview
For hematologists/oncologists, the initiative addresses the real-world burden of anemia in LR-MDS, risk assessment tools, genetic mutations influencing treatment, safety and efficacy trial data of therapeutic options, monitoring and mitigating adverse events, and the importance of interdisciplinary care teams in optimizing patient outcomes.
For primary care providers, the initiative emphasizes recognizing anemia, ensuring timely care and referrals to specialists, understanding the impact on patient quality of life, managing comorbidities, available treatment options, identifying adverse events, integrating with interdisciplinary care teams, and creating personalized care plans considering healthcare barriers and shared decision-making.
[Thumbnail of Video]
[Faculty Headshot] Name
@Faculty handle
Review the role of the primary care provider in the coordination of care for patients with anemia including proper evaluation and referral.
Click here to take this activity for CME credit
[trackable MLI link to course on LMS]
[Thumbnail of Video]
[Faculty Headshot] Name
@Faculty handle
Appropriately evaluate the underlying causes of anemia, including a suspected hematologic malignancy such as MDS.
[Link to course on LMS]
[Thumbnail of Video]
[Faculty Headshot] Name
@Faculty handle
Develop long-term, individualized care plans for anemia management for patients with LR-MDS.
[Link to course on LMS]
[Thumbnail of Video]
[Faculty Headshot] Name
@Faculty handle
Appropriately evaluate the efficacy and safety of the newest game-changing therapies to optimize clinical outcomes for patients with symptomatic anemia and LR-MDS h symptomatic anemia.
[Link to course on LMS]
[Thumbnail of Video]
[Faculty Headshot] Name
@Faculty handle
Appropriately evaluate efficacy and safety trial data of groundbreaking therapies to optimize clinical outcomes for patients with symptomatic anemia and LR-MDS.
[Link to course on LMS]
[Thumbnail of Video]
[Faculty Headshot] Name
@Faculty handle
Accurately assess patient and clinical risk factors in the diagnosis and prognosis of LR-MDS to guide treatment decisions that relieve the burden of symptomatic anemia
[Link to course on LMS]
[Thumbnail of Video]
[Faculty Headshot] Name
@Faculty handle
Evaluate risk factors and stratification criteria for MDS and associated anemia to determine prognosis and treatment strategies.
[Link to course on LMS]
[Thumbnail of Video]
[Faculty Headshot] Name
@Faculty handle
Utilize collaborative approaches to enhance health outcomes for individuals with symptomatic anemia
[Link to course on LMS]
[Thumbnail of Video]
[Faculty Headshot] Name
@Faculty handle
Appropriately evaluate the efficacy and safety of the newest game-changing therapies to optimize clinical outcomes for patients with symptomatic anemia and LR-MDS h symptomatic anemia.
[Link to course on LMS]
[Thumbnail of Video]
[Faculty Headshot] Name
@Faculty handle
Develop long-term, individualized care plans for anemia management for patients with LR-MDS.
[Link to course on LMS]